ConverGene LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ConverGene LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10952
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ConverGene LLC (ConverGene) is a small molecule discovery company that offers development of cancer drugs targeting the root regulatory mechanisms within cancer cells. The company develops small-molecule drugs that aim at bromodomains, a structural feature of proteins, which mediate epigenetic changes in deoxyribose nucleic acid and packaging proteins. ConverGene’s portfolio includes candidates for the treatment for solid and liquid tumours, and neurological psychiatric disorders. It develops compounds to treat two types of malignancies with orphan disease status, acute myelogenous leukemia and multiple myeloma, among others. The company works in partnership with universities, research institutes and drug development companies. ConverGene is headquartered in Cambridge, Maryland, the US.

ConverGene LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ConverGene LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ConverGene LLC, Medical Devices Deals, 2012 to YTD 2018 9
ConverGene LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ConverGene LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
ConverGene Raises USD0.85 Million in Venture Financing 11
Partnerships 12
ConverGene Enters into Research Agreement with MD Anderson Cancer Center 12
ConverGene Enters into Development Agreement with National Institute of Neurological Disorders and Stroke 13
ConverGene Enters into Research Agreement with University of Maryland School of Medicine 14
Licensing Agreements 15
ConverGene Enters into Licensing Agreement with National Center for Advancing Translational Sciences 15
ConverGene LLC – Key Competitors 16
ConverGene LLC – Key Employees 17
ConverGene LLC – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
ConverGene LLC, Pharmaceuticals & Healthcare, Key Facts 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ConverGene LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ConverGene LLC, Deals By Therapy Area, 2012 to YTD 2018 8
ConverGene LLC, Medical Devices Deals, 2012 to YTD 2018 9
ConverGene LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ConverGene Raises USD0.85 Million in Venture Financing 11
ConverGene Enters into Research Agreement with MD Anderson Cancer Center 12
ConverGene Enters into Development Agreement with National Institute of Neurological Disorders and Stroke 13
ConverGene Enters into Research Agreement with University of Maryland School of Medicine 14
ConverGene Enters into Licensing Agreement with National Center for Advancing Translational Sciences 15
ConverGene LLC, Key Competitors 16
ConverGene LLC, Key Employees 17

List of Figures
ConverGene LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ConverGene LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ConverGene LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ConverGene LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pharming Group NV (PHARM):企業の財務・戦略的SWOT分析
    Pharming Group NV (PHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Osaka Gas Co., Ltd.:戦略・SWOT・企業財務分析
    Osaka Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Osaka Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Visteon Corp (VC):企業の財務・戦略的SWOT分析
    Visteon Corp (VC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Noble Corporation Plc (NE):石油・ガス:M&Aディール及び事業提携情報
    Summary Noble Corporation Plc (Noble) is an offshore drilling contractor for the oil and gas industry. It provides contract drilling services with its fleet of mobile offshore drilling units. The company’s offshore rig fleet operates in the global market and provides contract drilling services. Nobl …
  • Implenia AG:戦略・SWOT・企業財務分析
    Implenia AG - Strategy, SWOT and Corporate Finance Report Summary Implenia AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Xintela AB (XINT):企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also o …
  • Australian Postal Corporation:戦略・SWOT・企業財務分析
    Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report Summary Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ConvaTec Group Plc (CTEC):医療機器:M&Aディール及び事業提携情報
    Summary ConvaTec Group Plc (ConvaTec) is a medical products and technologies company that specializes in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its major products include wound dressings, skin care products, disposable infusion sets, urological catheter …
  • Sigma Pharmaceuticals Limited:企業の戦略・SWOT・財務情報
    Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report Summary Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Bankers Insurance Group:企業の戦略・SWOT・財務情報
    Bankers Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Bankers Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sentara Healthcare Inc:企業の戦略的SWOT分析
    Sentara Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Innovation Pharmaceuticals Inc (IPIX)-製薬・医療分野:企業M&A・提携分析
    Summary Innovation Pharmaceuticals Inc (Innovation Pharmaceuticals), formerly Cellceutix Corp is a biopharmaceutical company that offers discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications. The company offers kevetrin for t …
  • Indoco Remedies Ltd (INDOCO):製薬・医療:M&Aディール及び事業提携情報
    Summary Indoco Remedies Ltd (Indoco Remedies) is a research-oriented pharmaceutical company that manufactures and markets formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). It has products portfolio in various therapeutic segments such as cardiovascular, central nervo …
  • Akbank TAS (AKBNK):企業の財務・戦略的SWOT分析
    Akbank TAS (AKBNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • British American Tobacco p.l.c.:企業の戦略・SWOT・財務情報
    British American Tobacco p.l.c. - Strategy, SWOT and Corporate Finance Report Summary British American Tobacco p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Gas2Grid Ltd (GGX):石油・ガス:M&Aディール及び事業提携情報
    Summary Gas2Grid Ltd (Gas2Grid) is an oil and gas company that offers exploration and development of conventional oil and gas onshore Cebu Island in the Philippines, Aquitaine Basin in south-west France and the Canning Basin, Australia. The company explores and develops conventional oil and gas, coa …
  • Taita Chemical Co, Ltd (1309):企業の財務・戦略的SWOT分析
    Taita Chemical Co, Ltd (1309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • CareDx Inc (CDNA):企業の製品パイプライン分析2018
    Summary CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used …
  • ATLAS Oil Company:石油・ガス:M&Aディール及び事業提携情報
    Summary ATLAS Oil Company (ATLAS) is an oil and gas company that offers fuel supply and logistic services. The company’s services comprise supply, renewable fuels, bulk fueling, fuel on demand, logistics, fixed price contracts, frac site fueling, emergency refuel, crude hauling, transloading and on- …
  • Pakistan Water and Power Development Authority:企業の戦略的SWOT分析
    Pakistan Water and Power Development Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆